Søgning
Søgning på udtrykket 'uro' giver 40 resultater
Sider [2]
Kalender [10]
Nyt fra tidsskrifterne [+20]
Aktuelle smitsomme sygdomme [2]
d.
Infektionsmedicinsk afd. 8632, Rigshospitalet.
Delkursusledelse.
Marie Helleberg og Trine Mogensen.
Program.
Afventer.
Tidligere kurser.
30. og 31. januar 2023.
25. og 26. januar 2017.
Infektionshygiejne/profylakse, sepsis og urogenitale infektioner:
Dato for næste kursus.
2027:
Program.
Afventer.
Sted.
Hvidovre Hospital.
Delkursusledelse.
Rikke Krogh-Madsen og Michael Dalager-Pedersen.
Tidligere kurser.
11. og 12. juni 2024.
8. og 9. juni 2021.
15…
sor, overlæge Annmarie T. Lassen, Akut Modtageafsnit, OUH.
12.30 – 13.00.
Frokost.
13.00 – 15.45.
URINVEJSINFEKTIONER OG BOGSTAVBAKTERIER.
13.00 – 13.45.
Udredning og behandling af urinvejsinfektion i urologien.
Overlæge Karin Andersen, Urologisk Afdeling, OUH.
13.45 – 14.00.
Pause.
14.00 – 14.45.
Behandling af urinvejsinfektion set fra KMA.
Afdelingslæge Frederik Hertz, KMA, RH.
14.45 – 15.00…
Professor Henrik Nielsen kommenterer: Trods indiskutable fremskridt i den farmakologiske behandling af HIV/AIDS er der fortsat områder med plads til forbedring.
Blandt patienter i kronisk behandling er HAND (HIV-associated neurocognitive disorder) et af disse eksempler…
ndersøge de eksisterende, allerede markedsførte stoffer som har et anti-TB potentiale i kliniske studier. Linezolid er et af disse, men der er også andre antibiotika på hylden som burde undersøges bedre. Vi har tre nye stoffer godkendt til MDR TB i Europa: delaminid (Deltyba, dog ikke markedsført i DK) samt bedaquiline (Sirturo) også er et nyudviklet produkt medens Para-aminosalicylsyre (Granupas) blot er en om-formulering af det gamle produkt: PAS…
lev udført i 1973 og længe var det vanskeligt at have adgang til disse lægemidler udenfor Kina. Nu har anvendelsen af intravenøs artesunate imidlertid erstattet kinin og er blevet standard i Europa ved svær malaria. Som et fælles studie fra TropNet demonstrerer er det med høj effektivitet og yderst lav dødelighed selv ved alvorlig Plasmodium falciparum infektion. Historien bag artesunate kan opleves i Youyou Tus forelæsning på www.nobelprize.org/nobel_prizes/medicine/laureates/2015/tu-lecture.html
n (per oralt) blev undersøgt på ca. 700 Vietnamesiske patienter. Men der kunne desværre ikke erkendes nogen forskel i de to grupper. I en leder i samme nummer af NEJM henleder Peter Donald opmærksomheden på de gode behandlingsresultater man har i Cape Town med et kun 6 måneders regime som inkluderer Ethionamid (Trecator), Isoniazid, Rifamipcin og Pyrazinamid. Hvem har herefter opskriften på et nyt, etisk forsvarligt, klinisk studie til behandling af en af de mest alvorlige neuroinfektioner vi kender?
Professor Morten Sodemann kommenterer: Denne canadiske gennemgang af evidensniveauer for screening af forskellige sygdomme hos flygtninge/indvandrere er grundig og må være vigtig inspirations kilde i Danmark. Europa er som sædvanlig uenige også på dette punkt - her er en gennemgang af europæiske landes meget varierede tilgang til screening af flygtninge og immigranter:. www.mdpi.com/1660-4601/11/10/11004
at skrive lærebøgerne om. I to årtier har WHO på baggrund af Mantoux-test skønnet, at ca. en tredjedel af jordens befolkning er inficeret med Mycobacterium tuberculosis. Det nye skøn fra den nordiske forfattergruppe, som for nylig er publiceret i European Respiratory Journal, nedjusterer det til knap en fjerdedel af jordens befolkning. Dette svarer også til WHO's seneste skøn fra 2016…
14. oktober 2026, Maastricht, Holland
3. juni 2026, Belfast, Nordirland
17. april 2026, München, Tyskland
19. november, Online og Warszawa, Polen
15. oktober, Paris, Frankrig
29. september, Hamborg, Tyskland
27. september, Amsterdam, Nederlandene
17. september, Thessaloniki, Grækenland
11. september, Bologna, Italien
4. juni, Barcelona, Spanien
Nyt fra tidsskrifterne [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?
BMC Infectious Diseases
26.04.2025
. Background. Urinary tract infections are disproportionately prevalent in low- and middle-income countries, where a significant portion of the population relies on over the counter and self-prescriptions to manage symptoms. This practice has contributed to a concerning shift in antimicrobial resistance trends, among the most recommended treatments. . Methods…
Infection and Immunity
11.04.2025
Infection and Immunity, Ahead of Print.
PLoS One Infectious Diseases
4.04.2025
from female patients from 2019 to 2022 to assess trends in UTI burden, prevalence stratified by age and month, and antimicrobial susceptibility patterns. In all, urine pathogens were isolated in 4475 (39.67%) of the samples tested. Of the total number of uropathogens isolated, majority of them were bacterial pathogens (94.21%), with an increasing proportion of fungal infections, specifically candida species (5.79%)…
Antimicrobial Agents And Chemotherapy
4.04.2025
Antimicrobial Agents and Chemotherapy, Ahead of Print.
PLoS One Infectious Diseases
27.02.2025
by Charlotte J. van Ginkel, Cléo D.M. Baars, Dorien M. Tiemessen, Cornelius F.J. Jansen, Frank M.J. Martens, Jack A. Schalken, Dick A.W. Janssen . Disruption of the glycosaminoglycan (GAG)-layer and urothelial barrier is an important aspect of the pathophysiology of bladder pain syndrome/ interstitial cystitis. Intravesical hyaluronic acid (HA) is often used in treatments for IC/BPS, however the role in the urothelial barrier is unknown…
BMC Infectious Diseases
26.02.2025
. Abstract. . Background. Uropathogenic Escherichia coli (UPEC) is the predominant cause of urinary tract infections (UTIs), and the recurrence of these infections poses significant treatment challenges. . . . Objective…
Antimicrobial Agents And Chemotherapy
25.02.2025
Antimicrobial Agents and Chemotherapy, Ahead of Print.
PLoS One Infectious Diseases
19.02.2025
by Priyanka Balaji, Madhana Priya N, Emmanuel Bhaskar M., Gnanasambandan R, Solomon F. D. Paul, Magesh R. . Urinary tract infections caused by uropathogenic Escherichia coli (E. coli) are a global health concern, with rising rates and antibiotic resistance demanding novel treatments. Therefore, in this study, we explored the potential of Oxacyclohexadecan-2-one obtained from Moringa oleifera (M. oleifera) seed, as antibacterial agent against three majorly prevalent carbapenemase-producing E…
Science Advances
1.02.2025
Science Advances, Volume 11, Issue 5, January 2025.
BMC Infectious Diseases
25.01.2025
t. . Background. Urinary tract infections (UTIs) are a significant global health issue, especially among women, with growing concerns related to antibiotic resistance and adverse effects. The Uromune®, a sublingual, heat-inactivated, polybacterial vaccine, represents a promising therapeutic alternative by enhancing immune responses against uropathogens. . . . Methods…
PLoS One Infectious Diseases
24.01.2025
by Syed Muktadir Al Sium, Barna Goswami, Sanjana Fatema Chowdhury, Showti Raheel Naser, Mihir Kanti Sarkar, Md. Jobaid Faruq, Md. Ahashan Habib, Shahina Akter, Tanjina Akhtar Banu, Md. Murshed Hasan Sarkar, Md. Salim Khan . The gram-negative, facultative anaerobic bacterium Morganella morganii is linked to a number of illnesses, including nosocomial infections and urinary tract infections (UTIs)…
PLoS One Infectious Diseases
10.01.2025
by Jessica M. Gilbertie, Breanna J. Sheahan, Shelly L. Vaden, Megan E. Jacob . Urinary tract infections (UTIs) are among the most common bacterial infections of both dogs and humans, with most caused by uropathogenic Escherichia coli (UPEC). Recurrent UPEC infections are a major concern in the treatment and management of UTIs in both species. In humans, the ability of UPECs to form intracellular bacterial communities (IBCs) within urothelial cells has been implicated in recurrent UTIs…
Virulence
28.12.2024
Volume 16, Issue 1, December 2025 .
Emerging Infectious Diseases
24.12.2024
Research - Neisseria meningitidis Serogroup Y Sequence Type 1466 and Urogenital Infections
PLoS One Infectious Diseases
28.11.2024
by Grayson K. Walker, M. Mitsu Suyemoto, Megan E. Jacob, Siddhartha Thakur, Luke B. Borst . Uropathogenic Escherichia coli (UPEC) and avian pathogenic Escherichia coli (APEC) are extraintestinal pathogenic Escherichia coli (ExPEC) that infect dogs and poultry. These agents occur both as single-species infections and, commonly, in co-infection with Enterococcus faecalis (EF); however, it is unclear how EF co-infections modulate ExPEC virulence…
BMJ Open
14.11.2024
d laboratory characteristics on stone composition to fill the research gap. . Setting. A retrospective observational study was performed in Shenzhen between December 2019 and August 2022. . Participants. A total of 858 calculi samples from patients with urolithiasis were analysed via infrared spectroscopy. . Methods. The stone was classified by the European Association of Urology guidelines and the Mayo Clinic stone classification practices…
Clinical Microbiology and Infection
8.11.2024
Diagnosing a urinary tract infection involves quantifying uropathogenic microorganisms in patients' urine samples with significant bacteriuria often defined as 104 – 105 bacteria per milliliter [1]. Many urine samples are contaminated by urogenital commensals, that may rapidly proliferate in urine leading to false-positive culture results [2]…
Proceedings of the National Academy of Sciences
26.09.2024
Proceedings of the National Academy of Sciences, Volume 121, Issue 39, September 2024.
American Journal of Tropical Medicine and Hygiene
8.08.2024
. . Journal Name: The American Journal of Tropical Medicine and Hygiene Volume: 111 Issue: 2 Pages: 387-390. .
Infection
24.06.2024
nal disease (T5/6, T11/12, L3/4) in keeping with STB. After informed consent and recruitment into the Spinal TB X Cohort, the patient underwent PET/CT as per protocol, which revealed isolated multilevel STB (T4-7, T11/12, L3/4) with no concomitant lung or urogenital lesion. However, sputum and urine were Xpert MTB/RIF Ultra positive and Mtb was cultured from the urine sample…
Aktuelle smitsomme sygdomme [2]
Aktuelle smitsomme sygdomme [2]
ProMED
16.04.2025
uncomplicated gonorrhoea,' trial investigators wrote. . For the EAGLE-1 trial, USA, UK, and Australian investigators enrolled. 628 participants from Australia, Germany, Mexico, Spain, and the USA. who were ages 12 and over and had suspected uncomplicated urogenital. gonorrhea, a positive lab test for _N. gonorrhoeae_, or both. Participants were randomized 1:1 to receive two 3000 milligram (mg). doses of oral gepotidacin or 500 mg intramuscular ceftriaxone plus 1. gram of oral azithromycin…
Medscape Infectious Diseases
13.02.2025
Dr David Johnson explores recent data with urolithin A, a gut metabolite that’s shown early promise in studies with portal hypertension. . Medscape Gastroenterology